List of Tables
Table 1 Technological Advancements in Diagnostic Imaging Systems
Table 2 Key Investments By Government Bodies in the Diagnostic Imaging Market
Table 3 Lymphedema Diagnostics Market, By Technology, 2017-2024 (USD Million)
Table 4 Comparison of Diagnostic Imaging Tests for Lymphedema
Table 5 Lymphoscintigraphy Market, By Region, 2017-2024 (USD Million)
Table 6 Lymphoscintigraphy Market, By Country, 2017-2024 (USD Million)
Table 7 Magnetic Resonance Imaging Market, By Region, 2017-2024 (USD Million)
Table 8 Magnetic Resonance Imaging Market, By Country, 2017-2024 (USD Million)
Table 9 Ultrasound Imaging Market, By Region, 2017-2024 (USD Million)
Table 10 Ultrasound Imaging Market, By Country, 2017-2024 (USD Million)
Table 11 Computed Tomography Market, By Region, 2017-2024 (USD Million)
Table 12 Computed Tomography Market, By Country, 2017-2024 (USD Million)
Table 13 X-Ray Lymphography Market, By Region, 2017-2024 (USD Million)
Table 14 X-Ray Lymphography Market, By Country, 2017-2024 (USD Million)
Table 15 Bioimpedance Analysis Market, By Region, 2017-2024 (USD Million)
Table 16 Bioimpedance Analysis Market, By Country, 2017-2024 (USD Million)
Table 17 Near-Infrared Fluorescence Imaging Market, By Type, 2017-2024 (USD Million)
Table 18 Near-Infrared Fluorescence Imaging Market, By Region, 2017-2024 (USD Million)
Table 19 Near-Infrared Fluorescence Imaging Market, By Country, 2017-2024 (USD Million)
Table 20 ICG Lymphography Market, By Region, 2017-2024 (USD Million)
Table 21 ICG Lymphography Market, By Country, 2017-2024 (USD Million)
Table 22 Fluorescein Sodium Microlymphangiography Market, By Region, 2017-2024 (USD Million)
Table 23 Fluorescein Sodium Microlymphangiography Market, By Country, 2017-2024 (USD Million)
Table 24 Lymphedema Diagnostics Market, By Disease Type, 2017-2024 (USD Million)
Table 25 Market for Cancer, By Region, 2017-2024 (USD Million)
Table 26 Market for Inflammatory Diseases, By Region, 2017-2024 (USD Million)
Table 27 Market for Cardiovascular Disease, By Region, 2017-2024 (USD Million)
Table 28 Market for Other Diseases, By Region, 2017-2024 (USD Million)
Table 29 Market, By End User, 2017-2024 (USD Million)
Table 30 Market for Hospitals, By Region, 2017-2024 (USD Million)
Table 31 Market for Diagnostic Centers, By Region, 2017-2024 (USD Million)
Table 32 Lymphedema Diagnostics Market for Research & Academic Institutes, By Region, 2017-2024 (USD Million)
Table 33 Market for Other End Users, By Region, 2017-2024 (USD Million)
Table 34 Market, By Region, 2017-2024 (USD Million)
Table 35 Market, By Country, 2017-2024 (USD Million)
Table 36 North America: Market, By Country, 2017-2024 (USD Million)
Table 37 North America: Market, By Technology, 2017-2024 (USD Million)
Table 38 North America: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 39 North America: Market, By Disease Type, 2017-2024 (USD Million)
Table 40 North America: Market, By End User, 2017-2024 (USD Million)
Table 41 US: Market, By Technology, 2017-2024 (USD Million)
Table 42 US: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 43 US: Market, By Disease Type, 2017-2024 (USD Million)
Table 44 US: Market, By End User, 2017-2024 (USD Million)
Table 45 Canada: Market, By Technology, 2017-2024 (USD Million)
Table 46 Canada: Lymphedema Diagnostics Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 47 Canada: Market, By Disease Type, 2017-2024 (USD Million)
Table 48 Canada: Market, By End User, 2017-2024 (USD Million)
Table 49 Europe: Market, By Country, 2017-2024 (USD Million)
Table 50 Europe: Market, By Technology, 2017-2024 (USD Million)
Table 51 Europe: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 52 Europe: Market, By Disease Type, 2017-2024 (USD Million)
Table 53 Europe: Market, By End User, 2017-2024 (USD Million)
Table 54 Germany: Market, By Technology, 2017-2024 (USD Million)
Table 55 Germany: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 56 Germany: Market, By Disease Type, 2017-2024 (USD Million)
Table 57 Germany: Market, By End User, 2017-2024 (USD Million)
Table 58 France: Lymphedema Diagnostics Market, By Technology, 2017-2024 (USD Million)
Table 59 France: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 60 France: Market, By Disease Type, 2017-2024 (USD Million)
Table 61 France: Market, By End User, 2017-2024 (USD Million)
Table 62 UK: Market, By Technology, 2017-2024 (USD Million)
Table 63 UK: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 64 UK: Market, By Disease Type, 2017-2024 (USD Million)
Table 65 UK: Market, By End User, 2017-2024 (USD Million)
Table 66 RoE: Market, By Technology, 2017-2024 (USD Million)
Table 67 RoE: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 68 RoE: Lymphedema Diagnostics Market, By Disease Type, 2017-2024 (USD Million)
Table 69 RoE: Market, By End User, 2017-2024 (USD Million)
Table 70 Asia Pacific: Market, By Country, 2017-2024 (USD Million)
Table 71 Asia Pacific: Market, By Technology, 2017-2024 (USD Million)
Table 72 Asia Pacific: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 73 Asia Pacific: Market, By Disease Type, 2017-2024 (USD Million)
Table 74 Asia Pacific: Market, By End User, 2017-2024 (USD Million)
Table 75 China: Market, By Technology, 2017-2024 (USD Million)
Table 76 China: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 77 China: Market, By Disease Type, 2017-2024 (USD Million)
Table 78 China: Market, By End User, 2017-2024 (USD Million)
Table 79 Japan: Market, By Technology, 2017-2024 (USD Million)
Table 80 Japan: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 81 Japan: Lymphedema Diagnostics Market, By Disease Type, 2017-2024 (USD Million)
Table 82 Japan: Market, By End User, 2017-2024 (USD Million)
Table 83 India: Market, By Technology, 2017-2024 (USD Million)
Table 84 India: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 85 India: Market, By Disease Type, 2017-2024 (USD Million)
Table 86 India: Market, By End User, 2017-2024 (USD Million)
Table 87 RoAPAC: Market, By Technology, 2017-2024 (USD Million)
Table 88 RoAPAC: Lymphedema Diagnostics Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 89 RoAPAC: Market, By Disease Type, 2017-2024 (USD Million)
Table 90 RoAPAC: Market, By End User, 2017-2024 (USD Million)
Table 91 RoW: Market, By Region, 2017-2024 (USD Million)
Table 92 RoW: Market, By Technology, 2017-2024 (USD Million)
Table 93 RoW: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 94 RoW: Market, By Disease Type, 2017-2024 (USD Million)
Table 95 RoW: Market, By End User, 2017-2024 (USD Million)
Table 96 Latin America: Lymphedema Diagnostics Market, By Technology, 2017-2024 (USD Million)
Table 97 Latin America: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 98 Latin America: Market, By Disease Type, 2017-2024 (USD Million)
Table 99 Latin America: Market, By End User, 2017-2024 (USD Million)
Table 100 Middle East & Africa: Market, By Technology, 2017-2024 (USD Million)
Table 101 Middle East & Africa: Market for Near-Infrared Fluorescence Imaging, By Type, 2017-2024 (USD Million)
Table 102 Middle East & Africa: Market, By Disease Type, 2017-2024 (USD Million)
Table 103 Middle East & Africa: Market, By End User, 2017-2024 (USD Million)
Table 104 Product Launches, Enhancements, & Approvals
Table 105 Partnerships, Collaborations, & Agreements
Table 106 Acquisitions
Table 107 Expansions
List of Figures
Figure 1 Lymphedema Diagnostics Market: Research Methodology Steps
Figure 2 Research Design
Figure 3 Breakdown of Primaries: Global Market
Figure 4 Research Methodology: Hypothesis Building
Figure 5 Market Size Estimation: Market
Figure 6 Data Triangulation Methodology
Figure 7 Market, By Technology, 2019 vs 2024 (USD Million)
Figure 8 Geographic Analysis: Lymphedema Diagnostics Market, By Disease Type, 2019
Figure 9 Market, By End User, 2019 vs 2024
Figure 10 Geographical Snapshot of the Market
Figure 11 Rising Prevalence of Lymphedema-A Major Factor Driving the Market for Lymphedema Diagnostics
Figure 12 North America to Account for the Largest Share of the Lymphedema Diagnostics Market, By Disease Type, in 2019
Figure 13 Near-Infrared Fluorescence Imaging to Register the Highest Growth in the Market During the Forecast Period
Figure 14 ICG Lymphography Segment Will Continue to Dominate the Near-Infrared Fluorescence Imaging Market in 2024
Figure 15 China to Register the Highest Growth During the Forecast Period
Figure 16 Lymphedema Diagnostics Market: Drivers, Restraints, Opportunities, and Challenges
Figure 17 North America: Market Snapshot
Figure 18 Europe: Market Snapshot
Figure 19 Asia Pacific: Market Snapshot
Figure 20 GE Healthcare Held the Leading Position in the Market in 2018
Figure 21 Market (Global) Competitive Leadership Mapping, 2018
Figure 22 GE Healthcare: Company Snapshot
Figure 23 Siemens AG: Company Snapshot
Figure 24 Philips: Company Snapshot
Figure 25 Canon, Inc.: Company Snapshot
Figure 26 Shimadzu Corporation: Company Snapshot
Figure 27 Stryker Corporation: Company Snapshot
Figure 28 Hitachi, Ltd.: Company Snapshot
Figure 29 Neusoft Corporation: Company Snapshot
Figure 30 Impedimed Limited: Company Snapshot